The TESCREAL bundle: Eugenics and the promise of utopia through artificial general intelligence
By Timnit Gebru and Émile P. Torres,
First Monday
| 04. 14. 2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can and should be built, researchers are working to create “safe AGI” that is “beneficial for all of humanity.” We argue that, unlike systems with specific applications which can be evaluated following standard engineering principles, undefined systems like “AGI” cannot be appropriately tested for safety. Why, then, is building AGI often framed as an unquestioned goal in the field of AI? In this paper, we argue that the normative framework that motivates much of this goal is rooted in the Anglo-American eugenics tradition of the twentieth century. As a result, many of the very same discriminatory attitudes that animated eugenicists in the past (e.g., racism, xenophobia, classism, ableism, and sexism) remain widespread within the movement to build AGI, resulting in systems that harm marginalized groups and centralize power, while using the language of “safety” and “benefiting humanity” to evade...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...